The poster child for strong patent protection is usually the pharmaceutical industry, as drugs are easily copied and can cost upwards of a billion dollars to develop. Here, Boldrin and Levine admit that the government would likely need to step in. But rather than giving companies a legal monopoly over their formulas, the authors suggest we should modify the drug approval process to let makers start recouping their costs faster. They would also set up a prize system to reward companies that invent the new medicines we need.The Case for Abolishing Patents (Yes, All of Them) - Business - The Atlantic
Caution, this is rather rough.
(via Drugs that cause most harm: Scoring drugs | The Economist — a reprise of the Nutt et al. graph that relates to this BBC Radio 4 item; oh, and I would like to see the number of users plotted on a third dimension, possibly bar height)
Elizabeth Pisani uses unconventional field research to understand how real-world behaviors influence AIDS transmission — and to overhaul antiquated, ineffective prevention strategies.Elizabeth Pisani: Sex, drugs and HIV — let’s get rational | Video on TED.com